Doxazosin Tablet
Product Images NDC 16729-415

Each tablet contains 1 mg of Doxazosin Mesylate USP. It is a prescription medication and dosage details can be found in the accompanying prescribing information. The tablets should be stored at 68° to 77°F with excursions permitted to 59° to 86°F. The medication is manufactured by Intas Pharmaceuticals Limited, India, and is distributed by Accord Healthcare, Inc., Durham, NC. The product is available in a well-closed container and comes with a patient information leaflet. The Lot and EXP & Data ralrix can be found in the blank and amish free area.*

This is a medication containing Doxazosin Mesylate USP equivalent to 2mg Doxazosin. The dosage and usage are mentioned in the accompanying prescribing information. The tablets should be stored at a temperature between 68°F to 77°F, with excursions permitted between 59°F to 86°F. The medication should be dispensed in a well-closed container. The manufacturer is Infas Pharmaceuticals Limited and it is distributed by Accord Healthcare, Inc. There is also a lot and EXP data mentioned.*

Each tablet contains Doxazosin Mesylate USP equivalent to 4mg Doxazosin. The tablets have an NDC code of 16720-213-01. The tablets can be stored at a temperature ranging from 15°C to 80°C. The label contains instructions for dispensing and storage, such as keeping the package clean, tracking Lot and EXP data, and dispensing only with the attached patient information leaflet. The tablets come in a well-closed container and are manufactured by Accord Healthcare, Inc. The manufacturer's information is included on the label.*

This is a description of a medication called Doxazosin Mesylate. It comes in tablet form, with each tablet containing 8 mg of Doxazosin Mesylate USP. The dosage and usage details are not provided in the text, and the reader is instructed to refer to the accompanying prescribing information. The medication should be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The manufacturer is Accord Healthcare, Inc., based in Durham, NG 27703. The tablets are manufactured by Intas Pharmaceuticals Limited, located in Ahmedabad - 382 210, INDIA. The text also includes the product code: NDG 16729-415-01. The pharmacist is advised to dispense the medication along with the attached patient information leaflet.*

The text is a table presenting effectiveness data in placebo-controlled trials for different studies. It includes information such as maximum flow rate, symptom score, baseline, and change. The table also mentions the type of questionnaire used to measure the symptoms and whether the dosage was fixed or titrated. There is additional information regarding the endpoints and dosages used in each study.*

This appears to be a table showing the mean increase in maximum urinary flow rate and mean change in total symptom score from baseline for a pharmaceutical product being compared to a placebo in a clinical trial. There is also a note indicating that doxazosin titration was up to a maximum of 8 mg and statistical significance is noted in the results (compared to placebo and baseline).*